Oxygen-containing fused tricyclic derivative, and preparation method therefor and use thereof
Patent Information
- Application Number
- HK62026126308
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-12-08
- Filing Date
- 2026-07-17
- Publication Date
- 2026-09-11
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480040800.8 (22) Application Date 2024.07.26 (66) Domestic Priority Data 202310930530.5 2023.07.27 CN 202311681118.0 2023.12.08 CN (85) PCT International Application Entering National Phase Date 2025.12.18 (86) PCT International Application Application Data PCT / CN2024 / 107786 2024.07.26 (87) PCT International Application Publication Data WO2025 / 021189 ZH 2025.01.30 (71) Applicant Shanghai Tuojie Biomedical Technology Co., Ltd. Address 201203 Room 103, Building 14, No. 3728 Jinke Road, Shanghai Pudong New Area Free Trade Zone (72) Inventors: Li Yunfei, Liu Haomiao, Tan Liang, Li Jian (74) Patent Agency: Beijing Gecheng Intellectual Property Agency Co., Ltd. 11314 Patent Attorney: Cheng Wei (51) Int.Cl. C07D 498 / 06 (2006.01) A61P 35 / 00 (2006.01) A61K 31 / 5383 (2006.01) (54) Invention Title: An Oxygen-Containing Fused Tricyclic Derivative and Its Preparation Method and Use (57) Abstract: An oxygen-containing fused tricyclic derivative and its preparation method and use are provided. Specifically, a compound of formula (I) or a pharmaceutically usable salt thereof is provided. The compound of formula (I) can be used as a cyclin-dependent kinase inhibitor for the prevention and / or treatment of diseases related to cyclin-dependent kinase. The substituents in formula (I) are defined as described in the specification. CN 121399137 A 2026.01.23 CN 1 21 39 91 37 A
